Senseonics Holdings (SENS) Shareholder's Equity Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45% |
| Dec 31, 2025 | 468.75% |
| Sep 30, 2025 | 554.95% |
| Jun 30, 2025 | 16,287.54% |
| Mar 31, 2025 | 85.62% |
| Dec 31, 2024 | -146.25% |
| Sep 30, 2024 | -133.00% |
| Jun 30, 2024 | -98.90% |
| Mar 31, 2024 | -70.59% |
| Dec 31, 2023 | 1,489.60% |
| Sep 30, 2023 | 445.60% |
| Jun 30, 2023 | 229.57% |
| Mar 31, 2023 | 172.05% |
| Dec 31, 2022 | 98.61% |
| Sep 30, 2022 | 94.35% |
| Jun 30, 2022 | 105.10% |
| Mar 31, 2022 | 51.87% |
| Dec 31, 2021 | -28.77% |
| Sep 30, 2021 | -386.74% |
| Jun 30, 2021 | -689.40% |
| Mar 31, 2021 | -279.69% |
| Dec 31, 2020 | -1,565.89% |
| Sep 30, 2020 | -316.13% |
| Jun 30, 2020 | -361.04% |
| Mar 31, 2020 | -211.42% |
| Dec 31, 2019 | -112.14% |
| Sep 30, 2019 | -66.91% |
| Jun 30, 2019 | -85.65% |
| Mar 31, 2019 | 433.62% |
| Dec 31, 2018 | 880.61% |
| Sep 30, 2018 | 244.29% |
| Jun 30, 2018 | 778.91% |
| Mar 31, 2018 | 21.79% |
| Dec 31, 2017 | 249.01% |
| Sep 30, 2017 | 426.63% |
| Jun 30, 2017 | -16.81% |
| Mar 31, 2017 | -181.73% |
| Dec 31, 2016 | 49.71% |
| Sep 30, 2016 | 9,025.74% |
| Jun 30, 2016 | 31,869.54% |
| Mar 31, 2016 | 533,683.64% |
| Dec 31, 2015 | -222.55% |
| Sep 30, 2015 | -224.84% |
| Jun 30, 2015 | -742.69% |